España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Entera Bio
ENTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.40
0.06
2.56%
At close: -
$2.45
0.05
2.08%
After Hours: 7:44 PM EDT
Get Report
Comment
Entera Bio (ENTX) Forecast
News
Earnings
Entera Bio (ENTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Entera Bio (NASDAQ:ENTX) Stock
Entera Bio Stock (NASDAQ: ENTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Friday, November 08, 2024
Entera Bio Q3 2024 GAAP EPS $(0.08) Misses $(...
Benzinga Newsdesk
Monday, October 07, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Friday, September 27, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Wednesday, September 25, 2024
Entera Bio shares are trading higher after th...
Benzinga Newsdesk
Entera Bio And OPKO Health Announce PK/PD Res...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Friday, August 09, 2024
Entera Bio Q2 EPS $(0.06), Inline, Sales $57....
Benzinga Newsdesk
Thursday, August 01, 2024
Entera To Present EB613, Once Daily PTH(1-34)...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Monday, June 03, 2024
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks
Entera Bio Presents Phase 1 Clinical Data Of ...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Friday, May 10, 2024
Entera Bio Q1 EPS $(0.05) Beats $(0.06) Estim...
Benzinga Newsdesk
Monday, April 08, 2024
Entera Bio Announces Publication Of Oral PTH(...
Benzinga Newsdesk
Tuesday, April 02, 2024
HC Wainwright & Co. Maintains Buy on Entera B...
Benzinga Newsdesk
Tuesday, March 26, 2024
Entera Bio Announces Key Regulatory Milestone For Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling On Qualifying BMD As A Surrogate Endpoint For Osteoporosis Drugs is Expected Within 10 Months
Happy Mohamed
Wednesday, March 20, 2024
Entera Bio Announces Pharmacokinetic Data For...
Benzinga Newsdesk
Friday, March 08, 2024
Entera Bio FY23 EPS $(0.31) Vs $(0.41) YoY; A...
Benzinga Newsdesk
Monday, March 04, 2024
Entera Bio Regains Compliance With Nasdaq Min...
Benzinga Newsdesk
Friday, January 12, 2024
Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying
Avi Kapoor
Wednesday, January 03, 2024
Entera Bio Announced That It Received An Exte...
Benzinga Newsdesk
Monday, December 11, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Wednesday, November 29, 2023
Interim Results From Ongoing Clinical Study C...
Benzinga Newsdesk
Monday, October 16, 2023
Entera Bio Reports Rapid Pharmacodynamic Resp...
Benzinga Newsdesk
Wednesday, September 13, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Tuesday, September 12, 2023
Entera Bio Announces Collaboration with OPKO ...
Benzinga Newsdesk
Monday, September 11, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Wednesday, August 23, 2023
Bioventus And 3 Other Stocks Under $5 Insiders Are Buying
Lisa Levin
Wednesday, August 16, 2023
Entera Bio To Present Two Abstracts On Its On...
Benzinga Newsdesk
Monday, May 08, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Friday, May 05, 2023
Entera Bio: Q1 Earnings Insights
Benzinga Insights
Entera Bio Q1 EPS $(0.08) Beats $(0.12) Estim...
Benzinga Newsdesk
Tuesday, April 04, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Monday, April 03, 2023
Reported Earlier, Entera Bio Provides Guidance From FDA Type D Meeting Related To EB613 Pivotal Program
Happy Mohamed
Tuesday, March 28, 2023
HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk
Thursday, March 23, 2023
Entera Bio Regains Compliance With Nasdaq Listing Requirements
Happy Mohamed
Tuesday, March 07, 2023
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, March 06, 2023
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Wednesday, February 15, 2023
Entera Bio Announces FDA's Acceptance Of A Type D Meeting Review To Affirm Design Of The Pivotal, Phase 3 Protocol For EB613 PTH Mini Tablets, As The First Oral Osteoanabolic Treatment Of Post-Menopausal Osteoporosis
Happy Mohamed
Wednesday, January 04, 2023
Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, November 17, 2022
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Lisa Levin
Wednesday, November 16, 2022
Entera Bio And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Lisa Levin
Monday, November 14, 2022
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Lisa Levin
Friday, November 11, 2022
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Monday, October 24, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, October 17, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Show More
